The rapidly declining prevalence of Helicobacter pylori infection and widespread use of
potent anti-secretory drugs means peptic ulcer disease has become substantially less …

Background Helicobacter pylori is one of the most prevalent global pathogens and can lead
to gastrointestinal disease including peptic ulcers, gastric marginal zone lymphoma and …

Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important
cause of peptic ulcer disease and gastric cancer. H. pylorimay also have a role in …

Important progress has been made in the management of Helicobacter pylori infection and
in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role …

Background & Aims Helicobacter pylori infection is increasingly difficult to treat. The purpose
of these consensus statements is to provide a review of the literature and specific, updated …

Background Peptic ulcer disease is common with a lifetime prevalence in the general
population of 5–10% and an incidence of 0.1–0.3% per year. Despite a sharp reduction in …

Objective The objective of this study was to assess the efficacy, safety and tolerability of
vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter …

Background The introduction of proton pump inhibitors (PPIs) into clinical practice has
revolutionized the management of acid-related diseases. Studies in primary care and …

As one of the most prevalent infections globally, Helicobacter pylori (H. pylori) continues to
present diagnostic and therapeutic challenges for clinicians worldwide. Diagnostically, the …

Background The optimal duration for Helicobacter pylori (H. pylori) eradication therapy is
controversial, with recommendations ranging from 7 to 14 days. Several systematic reviews …